Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Editorial Volume 6 Issue 5

Quorum Sensing Inhibitor: A New Therapeutic Strategy

Rajesh K Das*

Department of Pharmaceutical Sciences, India

*Corresponding Author: Rajesh K Das, Department of Pharmaceutical Sciences, India.

Received: May 28, 2021; Published: April 01 , 2022

Abstract

The increasing resistance of antibiotics from the last few decades, it is crucial to find new techniques against pathogenic bacteria. Quorum sensing (QS) is the alternative target to introduce a new strategy. Synthetic and natural QSIs play a crucial role to inhibit these QS signals. In this article, I highlight some examples of QS inhibitors like natural and synthetic based QS inhibitors. This article focuses on the inhibition of QS mechanisms with some of its applications.

Keywords: Quorum Sensing; Antibiotics; Autoinducing Peptides

References

Citation

Citation: Rajesh K Das. “Quorum Sensing Inhibitor: A New Therapeutic Strategy". Acta Scientific Pharmaceutical Sciences 6.5 (2022): 01-02.

Copyright

Copyright: © 2022 Rajesh K Das. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US